GlassScriptPhysician profile
Brady Daniel Anderson
NPI 1598337636
$6,282.44
in general payments reported to CMS, 2019-2025
16 companies · $5,006 in 2025
The $5,006 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,277 · 2025: $5,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,655 · Travel and Lodging: $2,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,654.65 |
| Travel and Lodging | $2,627.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,868.51 | 2024-2025 | Pico, Grafix, Collagenase Santyl |
| Stryker Corporation | $1,868.69 | 2024-2025 | Prostep, Augment Injectable, Easyfuse |
| Smoky Mountain Surgical LLC | $131.50 | 2024-2025 | |
| Abbvie INC. | $89.58 | 2024-2025 | |
| Biocomposites INC | $71.43 | 2025 | Stimulan |
| Medtronic, INC. | $45.06 | 2025 | Intellis Adaptivestim |
| Amgen INC. | $33.42 | 2024-2025 | Krystexxa |
| Acera Surgical, INC. | $24.79 | 2025 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $24.33 | 2025 | Exparel, Iovera |
| Bioventus LLC | $22.28 | 2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $20.71 | 2025 | |
| Ossur Americas, INC. | $20.20 | 2025 | |
| Fidia Pharma USA INC. | $17.49 | 2025 | Hymovis, Triluron |
| Solventum Corporation | $17.46 | 2025 | Activ.A.C. |
| Paratek Pharmaceuticals, INC. | $16.61 | 2025 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $10.38 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brady Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.